There is a growing number of new therapies targeting different pathways that will revolutionize patient management strategies in castration-resistant prostate cancer (CRPC) patients. Today there are more clinical trial options for CRPC treatment than ever before. and there are many promising agents in late-stage clinical testing. The hypothesis that CRPC frequently remains driven by a... https://thebookmarkid.com/story19599641/the-pilgrimage-to-the-holy-face-of-lucca-in-1896-documents-and-news-from-the-archive-of-the-congregation-of-the-holy-face